Fulcrum Therapeutics Inc
Fulcrum Therapeutics Inc (FULC) Option Chain
Read more
Tracking the FULC option chain helps you see every strike and expiry on Fulcrum Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of FULC options activity at a glance. Use our scanner to monitor the FULC option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For FULC stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where FULC options are being actively traded, and where they are not.
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 21.38 | 0 | 0 | 0.40 | 1.70 | 0.20 | 4.00 | 2.00 | -45.65 | — | 2.15 | 0.00 | 2.15 | 0 | 0 | 78.63 |
| 46.85 | 0 | 0 | 1.45 | 0.70 | — | 2.15 | 3.00 | -18.48 | — | 2.15 | 0.00 | 2.15 | 0 | 0 | 53.15 |
| 66.56 | 20 | 0 | 0.75 | 0.00 | — | 0.75 | 4.00 | +8.70 | — | 1.95 | 0.30 | 1.65 | 0 | 1 | 33.44 |
| 79.42 | 0 | 0 | 2.15 | 0.00 | — | 2.15 | 5.00 | +35.87 | 0.45 | 4.10 | 1.30 | 0.98 | 0 | 0 | 20.58 |
| 87.33 | 0 | 0 | 3.80 | 0.00 | — | 3.80 | 6.00 | +63.04 | 0.20 | 4.40 | 2.30 | 0.00 | 0 | 0 | 12.67 |
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank93.65% High
- Market cap (M$)281
- 52 weeks high-76.62%
- 52 weeks low30.04%
- Analyst recommendationSell
4.00 - Target price$4.00
8.11% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-08-05
- P/E—
- Future P/E—
- EPS (ttm)-1.21
- EPS growth next 5 years63.32%
As of Nov 5, 2026